MSLN and Miyoshi myopathy: The therapeutic approach used for MM consists mostly of combination cisplatin and pemetrexed chemotherapy and mesothelin, glycoprotein normally expressed on the surface of mesothelial cells, remains to date the only marker used in the diagnosis of MM [6].